Clinical Trial: Combination of Mitomycin and Carboplatin in Neoadjuvant Therapy in BRCA-associated Triple-negative Locally Advanced Breast Cancer

U.S., Sept. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07821229) titled 'Combination of Mitomycin and Carboplatin in Neoadjuvant Therapy in BRCA-associated Triple-negative Locally Advanced Breast Cancer' on May 06.

Brief Summary: This study was designed to evaluate the safety and efficacy of neoadjuvant therapy with mitomycin and carboplatin in patients with BRCA-associated locally advanced triple-negative breast cancer.

Study Start Date: Sept. 27, 2022

Study Type: INTERVENTIONAL

Condition: Breast Cancer (Early Breast Cancer) BRCA 1 Gene Mutation BRCA 2 Gene Mutation

Intervention: PROCEDURE: Neoadjuvant Chemotherapy (NACT)

neoadjuvant chemotherapy according to the regimen of mitomycin in combinat...